NCT04647981View on ClinicalTrials.gov

Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

May 22, 2019

Primary Completion Date

December 15, 2020

Study Completion Date

January 2, 2021

Conditions
Non-Invasive Bladder Urothelial CarcinomaNon-Invasive Bladder Papillary Urothelial Carcinoma, Low GradeNon-Invasive Bladder Papillary Urothelial Carcinoma, High Grade
Interventions
OTHER

Xpert® Bladder Cancer Monitor Test

The urine sample is analyzed with the Xpert® Bladder Cancer Monitor test.

Trial Locations (1)

34070

Clinique Beau Soleil, Montpellier

Sponsors

Collaborators (1)

Cepheid
All Listed Sponsors
collaborator

Cepheid

INDUSTRY

collaborator

Team Languedoc Mutualité / Nouvelles technologies

UNKNOWN

lead

Clinique Beau Soleil

OTHER